FR2515518B1 - Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant - Google Patents

Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant

Info

Publication number
FR2515518B1
FR2515518B1 FR8120384A FR8120384A FR2515518B1 FR 2515518 B1 FR2515518 B1 FR 2515518B1 FR 8120384 A FR8120384 A FR 8120384A FR 8120384 A FR8120384 A FR 8120384A FR 2515518 B1 FR2515518 B1 FR 2515518B1
Authority
FR
France
Prior art keywords
immunobiological preparations
diagnosis
prevention
treatment
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8120384A
Other languages
English (en)
Other versions
FR2515518A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2515518A1 publication Critical patent/FR2515518A1/fr
Application granted granted Critical
Publication of FR2515518B1 publication Critical patent/FR2515518B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/72—Candida
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
FR8120384A 1981-11-03 1981-10-30 Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant Expired FR2515518B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE1/10344A BE890954A (fr) 1981-11-03 1981-11-03 Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant

Publications (2)

Publication Number Publication Date
FR2515518A1 FR2515518A1 (fr) 1983-05-06
FR2515518B1 true FR2515518B1 (fr) 1985-10-18

Family

ID=3862926

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8120384A Expired FR2515518B1 (fr) 1981-11-03 1981-10-30 Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant

Country Status (10)

Country Link
US (1) US4678748A (fr)
EP (1) EP0082890B1 (fr)
JP (1) JPS58183627A (fr)
AU (1) AU547928B2 (fr)
BE (1) BE890954A (fr)
CA (1) CA1180291A (fr)
CH (1) CH652032A5 (fr)
FR (1) FR2515518B1 (fr)
GB (1) GB2108384B (fr)
NL (1) NL188185C (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506373D0 (en) * 1985-03-12 1985-04-11 Axon Healthcare Ltd Antigens antibodies
AU2657495A (en) * 1994-05-23 1995-12-18 Research And Development Institute, Inc. Candida albicans adhesin as a vaccine
US6488929B2 (en) 1994-05-23 2002-12-03 Montana State University Candida albicans phosphomannan complex as a vaccine
US6309642B1 (en) 1997-04-28 2001-10-30 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
EP0834322A3 (fr) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Vaccins pour traiter des mycoses
US20030072775A1 (en) * 1997-04-28 2003-04-17 The Research And Development Institute Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
DE10112097A1 (de) * 2001-03-12 2002-10-02 Ingrid Menzel Verfahren zur Erfassung der Pathogenese und/oder zur Diagnose von 'transmissiblen spongiformen Enzephalopathien

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2598659A (en) * 1949-04-20 1952-06-03 American Cyanamid Co Preparation of diagnostic antigens
US3855063A (en) * 1970-07-03 1974-12-17 Morinaga Milk Industry Co Ltd Process for producing a microbial proteinous substance
GB1319114A (en) * 1970-11-04 1973-06-06 Vnii Biosinteza Belkovykh Vesc Microbiological method of preparing lipids
US3975517A (en) * 1972-05-25 1976-08-17 Canadian Patents And Development Limited Enteric disease vaccine
JPS516729B2 (fr) * 1972-07-04 1976-03-02
DE2452303A1 (de) * 1974-11-05 1976-05-13 Bayer Ag Extraktionsprodukte aus hefezellwandbestandteile enthaltendem material, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4138479A (en) * 1975-11-07 1979-02-06 Bayer Aktiengesellschaft Process for the preparation of immunopotentiating agents from components of yeast cell wall material
DD137403A1 (de) * 1978-06-26 1979-09-05 Gerhard Reuter Reagens-herstellung zum serologischen nachweis von mykose-antikoerpern
JPS5568299A (en) * 1978-11-18 1980-05-22 Sapporo Breweries Ltd Method of detecting microorganism harmful to brewage

Also Published As

Publication number Publication date
GB2108384A (en) 1983-05-18
AU547928B2 (en) 1985-11-14
EP0082890A1 (fr) 1983-07-06
JPS58183627A (ja) 1983-10-26
NL188185B (nl) 1991-11-18
EP0082890B1 (fr) 1986-07-30
NL8104979A (nl) 1983-06-01
US4678748A (en) 1987-07-07
CA1180291A (fr) 1985-01-02
GB2108384B (en) 1985-06-12
CH652032A5 (de) 1985-10-31
AU7691081A (en) 1983-05-05
NL188185C (nl) 1992-04-16
FR2515518A1 (fr) 1983-05-06
BE890954A (fr) 1982-05-03

Similar Documents

Publication Publication Date Title
RO76614A (fr) Procede pour la preparation des derives de 3,4-dehydroproline et d'acide 4,5-dehydropipecolique
MA18939A1 (fr) Procede de preparation d'un agent pour le traitement de theilerioses
NL194373B (nl) Werkwijze voor de bereiding van 3-hydroxy-ML-236B derivaten, bekend als M-4 en M-4'.
FR2554130B1 (fr) Procede de traitement d'alliages de titane
PT75499A (fr) Procede pour la preparation de l'alkanoilanilides
FR2623523B1 (fr) Procede de traitement thermique d'alliages de titane
FR2511668B1 (fr) Procede et composition pour le traitement de systemes aqueux
FR2500824B1 (fr) Acide 5,5'-azobis-salicylique et ses sels utiles notamment pour le traitement des affections inflammatoires de l'intestin
FR2515518B1 (fr) Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant
FR2666621B1 (fr) Produit et procede pour la diversion d'acide dans le traitement de formations souterraines.
FR2694575B1 (fr) Procede pour le traitement de revetements en mcralz.
MA21046A1 (fr) Procede destine au traitement complementaire de solutions aqueuses d'acide fluosilicique .
FR2657548B1 (fr) Procede de traitement de sable pour moules et/ou pour noyaux.
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
RO87007A (fr) Procede et installation pour la preparation de l'isomerose
FR2696179B1 (fr) Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes.
RO76126A2 (fr) PROCEDE POUR LA PREPARATION DES ACIDES ANTHRAQUINONE-2,6 ET 2,7-œISULFONIQUES
MA20994A1 (fr) Procede de preparation d'une composition pour le traitement des infections bacteriennes
OA06284A (fr) Procédé de préparation de compositions pour le traitement d'infections chroniques de trypanosomiase.
FR2583419B1 (fr) Procede pour la preparation de 2-bromo-a-ergocryptine et ses sels d'addition d'acides.
MA22061A1 (fr) Procede pour la preparation de l'acide 7-amino-3-methoxy methyl-ceph-3-eme-4-carboxylique et son utilisation.
FR2690152B1 (fr) Procede de preparation et de traitement de propulseurs.
BE798501A (fr) Medicament pour le traitement de l'ulcere et de la gastrite et son procede de fabrication